Profil
Actuellement, Richard Crowley est directeur de l'exploitation et vice-président exécutif de Novavax, Inc. Par le passé, M. Crowley a occupé les postes de vice-président directeur des opérations et de l'assurance de la qualité chez TerSera Therapeutics LLC, de coprésident et de directeur de l'exploitation chez Savient Pharmaceuticals, Inc. et de premier vice-président des opérations biopharmaceutiques chez ImClone LLC, ainsi que de directeur de la fabrication de produits biologiques chez BASF Bioresearch Corp. Il a obtenu un diplôme de premier cycle de l'université Denison et un diplôme d'études supérieures de l'université de Pennsylvanie.
Anciens postes connus de Richard Crowley
Sociétés | Poste | Fin |
---|---|---|
NOVAVAX, INC. | Chief Operating Officer | 20/11/2023 |
Crealta Pharmaceuticals LLC
Crealta Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Crealta Pharmaceuticals LLC operates as a specialty pharmaceutical company. The firm pursuing the acquisition of specialty pharmaceutical products with a focus on select therapeutic areas. The company was founded in August 2013 and is headquartered in Lake Forest, IL. | Corporate Officer/Principal | 01/01/2016 |
TerSera Therapeutics LLC
TerSera Therapeutics LLC Medical SpecialtiesHealth Technology TerSera Therapeutics LLC develops pharmaceutical products. Its therapeutic areas include allergy or immunology, CNS disorders, endocrinology, gastroenterology, infectious disease, oncology, orphan diseases, rheumatology, transplant-related therapies, urology, and women's health. The company was founded by Edward J. Fiorentino in 2016 and is headquartered in Lake Forest, IL. | Chief Operating Officer | - |
SAVIENT PHARMACEUTICALS INC | President | - |
BASF Bioresearch Corp. | Corporate Officer/Principal | - |
Formation de Richard Crowley
University of Pennsylvania | Graduate Degree |
Denison University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
NOVAVAX, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
Savient Pharmaceuticals, Inc.
Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
BASF Bioresearch Corp. | |
Crealta Pharmaceuticals LLC
Crealta Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Crealta Pharmaceuticals LLC operates as a specialty pharmaceutical company. The firm pursuing the acquisition of specialty pharmaceutical products with a focus on select therapeutic areas. The company was founded in August 2013 and is headquartered in Lake Forest, IL. | Health Technology |
TerSera Therapeutics LLC
TerSera Therapeutics LLC Medical SpecialtiesHealth Technology TerSera Therapeutics LLC develops pharmaceutical products. Its therapeutic areas include allergy or immunology, CNS disorders, endocrinology, gastroenterology, infectious disease, oncology, orphan diseases, rheumatology, transplant-related therapies, urology, and women's health. The company was founded by Edward J. Fiorentino in 2016 and is headquartered in Lake Forest, IL. | Health Technology |